TY  - GEN
AU  - Dios Huerta, Olaya de
AU  - Ramírez-González, María A
AU  - Gómez-Soria, Irene
AU  - Segura-Collar, Berta
AU  - Manosalva, Juliana
AU  - Megías, Diego
AU  - de Andrea, Carlos E
AU  - Fernández-Rubio, Leticia
AU  - Hernández-Laín, Aurelio
AU  - Sepúlveda-Sánchez, Juan Manuel
AU  - Rodriguez-Ruiz, Maria E
AU  - Pérez-Núñez, Ángel
AU  - Wainwright, Derek A
AU  - Gargini, Ricardo
AU  - Sánchez-Gómez, Pilar
PY  - 2024
DO  - 10.1136/jitc-2024-009210
UR  - https://hdl.handle.net/20.500.12105/25097
AB  - Background: Activating and inhibitory receptors of natural killer (NK) cells such as NKp, NKG2, or CLEC are highly relevant to cold tumors including glioblastoma (GBM). Here, we aimed to characterize the expression of these receptors in GBM to gain...
LA  - eng
PB  - BMJ Publishing Group
KW  - Central Nervous System Cancer
KW  - Immune Checkpoint Inhibitor
KW  - Macrophage
KW  - NK Cell Lectin-Like Receptor Subfamily K
KW  - Tumor microenvironment - TME
KW  - Animals
KW  - Brain Neoplasms
KW  - Cell Line, Tumor
KW  - Female
KW  - Glioblastoma
KW  - Humans
KW  - Immunotherapy
KW  - Killer Cells, Natural
KW  - Mice
KW  - NK Cell Lectin-Like Receptor Subfamily C
KW  - Tumor Microenvironment
TI  - NKG2C/ KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma
TY  - research article
ER  -